Dr. Linda McSwiggan

Senior Lecturer


School of Nursing & Health Sciences
11 Airlie Place

Phone Number:

+(44) 01382 388534

Email Address:



Linda is a senior lecturer at the School of Nursing and Health Sciences. Before coming to work in the University, she worked locally as a district nurse, health visitor and midwife. Initially, Linda worked in the University as a clinical research nurse, moving to a teaching post in the School of Nursing and Health Sciences in 2001. Linda is currently the Programme Lead for the MSc Nursing (full-time), School Lead for Employability and Enterprise, and School Lead for Interprofessional Education.


Linda's research interests lie broadly within the scope of addressing inequalities and, more specifically, on promoting the health and wellbeing of individuals, families and communities. She has experience of both quantitative and qualitative research methodologies and methods, and of multi-agency research collaborations with NHS colleagues and third sector services. In light of these varied interests and experiences, Linda is involved in the workstreams of both research groups within the School; that is, Long-term conditions and Maternal and infant health.

Wider professional activities

Member of RCN

Scottish contact for the Healthy Universities UK Network

Member of organising committees for the Scottish Health and Social Care Team Challenge (April 2016), the International Student Health and Social Care Team Challenge (September 2016), and the Global Health Challenge, University of Dundee (October 2016)

Member of the Maternal and Child Health Advisory Group for the Scottish Improvement Science Collaborating Centre (SISCC)


Linda contributes to teaching, learning and assessment in undergraduate, through to doctoral level programmes. She is a personal tutor for undergraduate students and supervises postgraduate students at Masters and PhD levels. Linda has a particular interest in supporting student engagement and academic achievement, which has led to her involvement in a number of innovative projects.


MCSWIGGAN, L.C., MARSTON, J., CAMPBELL, M., KELLY, T. and KROLL, T. Information sharing and knowledge exchange with respite care services for older adults: A qualitative exploration of carers’ experiences, Health and Social Care in the Community. DOI: 10.1111/hsc.12440

FULFORD, H., MCSWIGGAN, L.C., KROLL, T. and MACGILLIVRAY, S. (2016). Exploring the use of information and communication technology by people with mood disorder: A systematic review and meta-synthesis, JMIR Mental Health, DOI: 10.2196/mental.5966

MCSWIGGAN, L.C. and CAMPBELL, M. (2016). Can podcasts for assessment guidance and feedback promote self-efficacy among undergraduate nursing students: A qualitative study, Nurse Education Today. Vol 49, pp. 115-121. DOI: 10.1016/j.nedt.2016.11.021

O’CARROLL, V., MCSWIGGAN, L. and CAMPBELL, M. (2015). Health and social care professionals’ attitudes to interprofessional working and interprofessional education: A literature review. Journal of Interprofessional Care. 30(1):42-9. DOI: 10.3109/13561820.2015.1051614

ORR, L.C., ELLIOTT, L. and BARBOUR, R.S. (2014). Promoting family-focused approaches within adult drug services: The potential of the ‘Senses Framework’. International Journal of Drug Policy, DOI: 10.1016/j.drugpo.2014.04.011

ORR, L.C., et al., (2013) Involving families and carers in drug services:  are families' part of the problem'?  Families, Relationships and Societies, DOI: 10.1332/204674313X669900

ORR, L.C., BARBOUR, R.S. and ELLIOTT, L. (2012) Carer involvement with drug services: a qualitative study. Health Expectations, 6 Dec. DOI: 10.1111/hex.12033.

ELLIOTT, L., ORR, L.C., WATSON, L. AND JACKSON, A., (2005). Secondary prevention interventions for young drug users: a systematic review of the evidence. Adolescence, 40 (157), pp.1-22.

ELLIOTT, L., ORR, L., WATSON, L. AND JACKSON, A., (2005). How effective are secondary prevention interventions for young drug users? Family Therapy, 32 (1), pp.15-30.

ORR, L. C. ET AL. , (2003). Relationship between changes in quality of life and measures of lung function and bronchial hyper-responsiveness during high dose inhaled corticosteroid treatment in uncontrolled asthma. American Journal of Respiratory Medicine, 2 (5), pp.433-438.

WILSON, A. M. ET AL., (2003). Reproducibility of nasal function measurements with histamine and adenosine monophosphate nasal challenge testing in patients with allergic rhinitis. Allergology International, 52, pp.155-160.

WILSON A.M. ET AL, (2003). An evaluation of short-term corticosteroid response in perennial allergic rhinitis using histamine and adenosine monophosphate nasal challenge. British Journal of Clinical Pharmacology, 4, pp.354-359.

CURRIE, G. P. ET AL., (2002). Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma. Thorax, 57 (10), pp.865-868.

FOWLER, S. J. ET AL., (2002). Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone proprionate. Chest, 122 (2), pp.618-623.

WILSON, A. M. ET AL., (2002). A comparison of once daily fexofenadine versus the combination of montelukast plus loratidine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis. Clinical and Experimental Allergy, 32 (1), pp.126-132.

WILSON, A. M. ET AL., (2001). Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis. Annals of Allergy, Asthma and Immunology, 87 (4), pp.344-349.

FOWLER, S. J. ET AL., (2001). Dose response for adrenal suppression with HFA formulations of fluticasone propionate and beclomethasone diprprionate. British Journal of Clinical Pharmacology, 52 (1), pp.93-95.

WILSON, A.M. ET AL., (2001). Effects of monotherapy with intranasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clinical and Experimental Allergy, 31 (1), pp.61-68.

WILSON, A. ET AL. , (2000). Anti-asthmatic effects of mediator blockade versus topical corticosteroids in seasonal allergic rhinitis and asthma. American Journal of Respiratory and Critical Care Medicine, pp.1297-1301.